Adults 18 to 75, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Shared Decision Making Process ScorePrimary· Baseline survey
The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores for both versions of the scale range from 0-4 where higher values indicate a better shared decision making process occurred.
Measures decisional conflict, consists of 4 yes/no items. Scores range 0-4 where 0 indicates high decisional conflict, 4 indicates no decisional conflict, and scores less than or equal to 3 indicate decisional conflict. The measure is top-scored and we report the percentage of participants who scored a 4 ("no decisional conflict).
Group
Value
95% CI
Original Shared Decision Making Process Scale
63
Revised Shared Decision Making Process Scale
72
Decision Regret ScaleSecondary· Baseline survey
5-item decision regret scale ranges from 0-100 with higher scores indicating greater decisional regret.
Group
Value
95% CI
Original Shared Decision Making Process Scale
23
± 18
Revised Shared Decision Making Process Scale
21
± 20
Single-Item Measure of Decision RegretSecondary· Baseline survey
Single item asking "If you knew then what you know now, do you think you would make the same decision about depression?" Responses are definitely yes, probably yes, probably no and definitely no.
Group
Value
95% CI
Original Shared Decision Making Process Scale
119
Revised Shared Decision Making Process Scale
134
Original Shared Decision Making Process Scale
95
Revised Shared Decision Making Process Scale
102
Original Shared Decision Making Process Scale
15
Revised Shared Decision Making Process Scale
24
Original Shared Decision Making Process Scale
1
Revised Shared Decision Making Process Scale
4
Treatment PreferenceSecondary· Baseline survey
Single item asking "What did you want to do to manage your depression" with response options (1) Anti-depressant medicine alone, (2) Counseling or therapy alone, (3) Both medicine and counseling, and (4) Do something else.
Single item asking the participant who made the ultimate decision. The categorical response options are 1) the patient made the decision, 2)the provider made the decision, or 3) both patient and provider made the decision together.
Group
Value
95% CI
Original Shared Decision Making Process Scale
107
Revised Shared Decision Making Process Scale
125
Original Shared Decision Making Process Scale
32
Revised Shared Decision Making Process Scale
27
Original Shared Decision Making Process Scale
91
Revised Shared Decision Making Process Scale
112
Shared Decision Making Process Measure RetestSecondary· 1 week after baseline survey
The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process occurred.
Group
Value
95% CI
Original Shared Decision Making Process Scale
2.27
± 1.05
Revised Shared Decision Making Process Scale
2.58
± 0.97
Depression KnowledgeSecondary· Baseline survey
Multiple choice knowledge items for each topic will be combined to a total knowledge score (0-100) with higher scores indicating higher knowledge
Group
Value
95% CI
Original Shared Decision Making Process Scale
55.22
± 22.96
Revised Shared Decision Making Process Scale
55.98
± 21.87
AdherenceSecondary· Baseline survey
3 item measure of adherence to medication for sample participants who indicate that they are taking medicine. A total score is calculated with scores ranging form 0-100; higher values indicated greater medication adherence.
Group
Value
95% CI
Original Shared Decision Making Process Scale
83.6
± 18.47
Revised Shared Decision Making Process Scale
84.79
± 18.25
Sponsor's own description
The purpose of this study is to test two differently worded versions of the Shared Decision Making Process scale in a sample of adults who have recently made a decision about treatment of depression. The main goals are to gather evidence of reliability, to test whether the generic version has similar psychometric performance to the original, and to extend generalizability of the findings to younger adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or
· Phase 2
· recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
· EARLY_PHASE1
· recruiting
NCT07517549 — Sexual Health Education During Pregnancy
· NA
· recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression
· Phase 2
· recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression
· NA
· recruiting
Other Massachusetts General Hospital trials
Trials by the same sponsor.
NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
· withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg
· NA
· not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
· NA
· not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries
· NA
· not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation
· EARLY_PHASE1
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04343534.